Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemic cell death induced by antithymocyte globulin.

Ayami Yoshimi1, Masahumi Ito, Seiji Kojima

  • 1Department of Pediatrics/Developmental Pediatrics, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Leukemia Research
|May 17, 2005
PubMed
Summary

Antithymocyte globulin (ATG) directly kills T-cell leukemia cells and enhances this effect with serum complement. ATG induces cell death via a mechanism independent of Fas/Fas-ligand and caspases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-cryopreserved Kx negative packed red cell concentrates to support hematopoietic stem cell transplantation in McLeod contiguous gene deletion syndrome.

Journal of human immunity·2026
Same author

Progressive short stature in Pearson syndrome and the impact of organ failure.

Molecular genetics and metabolism·2026
Same author

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.

Nature genetics·2026
Same author

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Blood advances·2026
Same author

RUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series.

Frontiers in medicine·2025
Same author

Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

Blood cancer journal·2025

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Antithymocyte globulin (ATG) is used to treat T-cell malignancies.
  • The precise mechanisms of ATG-induced cytotoxicity in T-cell leukemia are not fully elucidated.
  • Understanding ATG's effects is crucial for optimizing leukemia treatment.

Purpose of the Study:

  • To investigate the cytotoxic effects of ATG on primary leukemic cells from patients with T-cell acute lymphoblastic leukemia (T-ALL).
  • To determine whether ATG-induced cell death involves direct cytotoxicity, complement-mediated lysis, or apoptosis.
  • To elucidate the specific pathways, including Fas/Fas-ligand and caspase activation, involved in ATG-mediated cell death.

Main Methods:

  • Primary leukemic cells from five T-ALL patients were incubated with ATG.

Related Experiment Videos

  • Cytolytic effects were assessed with and without human AB or baby rabbit serum.
  • Apoptosis was evaluated using Annexin-V binding and DNA fragmentation assays.
  • The role of Fas/Fas-ligand and caspases was investigated using anti-Fas monoclonal antibody (ZB4) and a broad caspase inhibitor (z-VAD FMK).

    • Main Results:

    • ATG demonstrated dose-dependent direct cytotoxicity against T-ALL cells.
    • Incubation with serum significantly enhanced ATG-induced cytolysis, indicating complement-mediated effects.
    • ATG treatment markedly increased Annexin-V binding, suggesting induction of apoptosis.
    • No significant DNA fragmentation was observed, and ATG-induced Annexin-V binding was not inhibited by anti-Fas or caspase inhibitors.
    • These findings indicate a Fas/Fas-ligand- and caspase-independent cell death pathway.

    Conclusions:

    • ATG exhibits both direct and complement-dependent cytotoxic activity against T-ALL cells.
    • ATG induces leukemic cell death through a pathway that does not rely on Fas/Fas-ligand or caspase activation.
    • These findings contribute to understanding ATG's mechanism of action in T-cell leukemia and may inform therapeutic strategies.